Dysplastic Nevi, Cutaneous Melanoma, and Other Skin Neoplasms in Patients with Myotonic Dystrophy Type 1: A Cross-Sectional Study

    January 2015 in “ Journal of The American Academy of Dermatology ”
    Anna Zampetti, Gabriella Silvestri, S. Manco, Katy Khamis, Marcella Masciullo, Marco Bianchi, Antonello Damiani, Massimo Santoro, Dennis Linder, Anthony Bewley, Claudio Feliciani
    New to Vitamin D? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study found that patients with myotonic dystrophy type 1 had higher numbers of nevi, dysplastic nevi, melanomas, and pilomatrixomas compared to age- and sex-matched controls.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    In a cross-sectional study with 90 patients with myotonic dystrophy type 1 (MD1) and 103 control subjects, it was found that individuals with MD1 had a significantly higher incidence of nevi, dysplastic nevi, and melanomas, despite the control group having more reported sunburns. The study also noted a higher occurrence of pilomatrixoma in MD1 patients. These findings suggest that MD1 may predispose individuals to skin tumors, and the authors recommend dermatological assessments for MD1 patients due to their increased risk. The study called for further research to understand the mechanisms behind this increased risk, including the role of vitamin D and genetic factors. The study's limitations included the lack of a standardized method for assessing prior sun exposure.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results